550 related articles for article (PubMed ID: 24141324)
1. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis.
Martin SS; Blaha MJ; Blankstein R; Agatston A; Rivera JJ; Virani SS; Ouyang P; Jones SR; Blumenthal RS; Budoff MJ; Nasir K
Circulation; 2014 Jan; 129(1):77-86. PubMed ID: 24141324
[TBL] [Abstract][Full Text] [Related]
2. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
[TBL] [Abstract][Full Text] [Related]
3. Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.
Mortensen MB; Falk E; Li D; Nasir K; Blaha MJ; Sandfort V; Rodriguez CJ; Ouyang P; Budoff M
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):221-230. PubMed ID: 28624395
[TBL] [Abstract][Full Text] [Related]
4. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
[TBL] [Abstract][Full Text] [Related]
6. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
7. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
AIM-HIGH Investigators
Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
[TBL] [Abstract][Full Text] [Related]
8. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).
Paramsothy P; Knopp RH; Bertoni AG; Blumenthal RS; Wasserman BA; Tsai MY; Rue T; Wong ND; Heckbert SR
J Am Coll Cardiol; 2010 Sep; 56(13):1034-41. PubMed ID: 20846602
[TBL] [Abstract][Full Text] [Related]
9. Does Lowering Low-Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle-Aged Adults? Analysis of the Observational MESA Study.
Liu K; Wilkins JT; Colangelo LA; Lloyd-Jones DM
J Am Heart Assoc; 2021 Jun; 10(11):e019695. PubMed ID: 33998284
[TBL] [Abstract][Full Text] [Related]
10. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
11. Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis.
Rikhi R; Schaich CL; Hafzalla GW; Patel NA; Tannenbaum JE; German CA; Polonsky T; Tsai MY; Ahmad MI; Islam T; Chevli PA; Shapiro MD
Eur J Prev Cardiol; 2024 Jun; 31(8):1048-1054. PubMed ID: 38323698
[TBL] [Abstract][Full Text] [Related]
12. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).
Budoff MJ; Young R; Burke G; Jeffrey Carr J; Detrano RC; Folsom AR; Kronmal R; Lima JAC; Liu KJ; McClelland RL; Michos E; Post WS; Shea S; Watson KE; Wong ND
Eur Heart J; 2018 Jul; 39(25):2401-2408. PubMed ID: 29688297
[TBL] [Abstract][Full Text] [Related]
13. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.
Blaha MJ; Budoff MJ; DeFilippis AP; Blankstein R; Rivera JJ; Agatston A; O'Leary DH; Lima J; Blumenthal RS; Nasir K
Lancet; 2011 Aug; 378(9792):684-92. PubMed ID: 21856482
[TBL] [Abstract][Full Text] [Related]
14. Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis).
Bittencourt MS; Blaha MJ; Blankstein R; Budoff M; Vargas JD; Blumenthal RS; Agatston AS; Nasir K
J Am Coll Cardiol; 2014 Feb; 63(5):434-43. PubMed ID: 24161320
[TBL] [Abstract][Full Text] [Related]
15. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
Flueckiger P; Qureshi W; Michos ED; Blaha M; Burke G; Sandfort V; Herrington D; Yeboah J
Clin Cardiol; 2017 Mar; 40(3):163-169. PubMed ID: 27859433
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).
Cao J; Nomura SO; Steffen BT; Guan W; Remaley AT; Karger AB; Ouyang P; Michos ED; Tsai MY
J Clin Lipidol; 2020; 14(1):109-121.e5. PubMed ID: 31882375
[TBL] [Abstract][Full Text] [Related]
17. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
18. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
Pletcher MJ; Bibbins-Domingo K; Liu K; Sidney S; Lin F; Vittinghoff E; Hulley SB
Ann Intern Med; 2010 Aug; 153(3):137-46. PubMed ID: 20679558
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
